Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen
RHEUMATOLOGY, cilt.58, sa.7, ss.1259-1267, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 58 Sayı: 7
- Basım Tarihi: 2019
- Doi Numarası: 10.1093/rheumatology/kez014
- Dergi Adı: RHEUMATOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1259-1267
- Anahtar Kelimeler: systemic lupus erythematosus, anti-phospholipid syndrome, contraception, epidemiology, COMBINED ORAL-CONTRACEPTIVES, VENOUS THROMBOSIS, ANTIPHOSPHOLIPID ANTIBODIES, NEUROPSYCHIATRIC EVENTS, PREGNANCY OUTCOMES, RISK, DIAGNOSIS, CRITERIA, CLASSIFICATION, CANCER
- İstanbul Üniversitesi Adresli: Evet
Özet
Objectives To assess the prevalence of combined hormonal contraceptives (CHCs) in reproductive-age women with SLE with and without possible contraindications and to determine factors associated with their use in the presence of possible contraindications.